These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17119491)

  • 1. [The routine prescription: between references and reality].
    Lachaux B
    Encephale; 2006 Oct; 32(5 Pt 3):S873-4. PubMed ID: 17119491
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.
    Boggs DL; Kelly DL; Love RC; McMahon RP; Conley RR
    Psychiatr Q; 2008 Jun; 79(2):111-9. PubMed ID: 18214677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
    Weinmann S; Janssen B; Gaebel W
    J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
    Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
    Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quotidien prescription: between references and reality].
    Verdoux H
    Encephale; 2006 Jan; 32 Pt 2():S10-1. PubMed ID: 16800079
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
    Chang YC; Lane HY
    J Clin Psychopharmacol; 2009 Aug; 29(4):391. PubMed ID: 19593183
    [No Abstract]   [Full Text] [Related]  

  • 7. Augmentation of risperidone with valproic acid.
    Chong SA; Tan CH; Lee EL; Liow PH
    J Clin Psychiatry; 1998 Aug; 59(8):430. PubMed ID: 9721824
    [No Abstract]   [Full Text] [Related]  

  • 8. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
    Taylor DM; Young CL; Mace S; Patel MX
    J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective study of clozapine use in Ile-de-France].
    Hiltgen S; Mantelet S; Pinabel F; Enjaume F
    Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine on trial.
    Mattes JA
    Am J Psychiatry; 1998 Jan; 155(1):153; author reply 153-5. PubMed ID: 9433359
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine with amisulpride for refractory schizophrenia.
    Agelink MW; Kavuk I; Ak I
    Am J Psychiatry; 2004 May; 161(5):924-5. PubMed ID: 15121665
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of risperidone to clozapine therapy in chronically psychotic inpatients.
    de Groot IW; Heck AH; van Harten PN
    J Clin Psychiatry; 2001 Feb; 62(2):129-30. PubMed ID: 11247102
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose bromocriptine in neuroleptic-resistant schizophrenia: a pilot study.
    Wolf MA; Diener JM; Lajeunesse C; Shriqui CL
    Biol Psychiatry; 1992 Jun; 31(11):1166-8. PubMed ID: 1356025
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
    Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
    Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode.
    Peuskens J; Kaufman L; Van Vleymen B
    Schizophr Res; 2007 Sep; 95(1-3):169-73. PubMed ID: 17630255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.